Coya Therapeutics, Inc 10-K for FY2023
Coya Therapeutics, Inc. (COYA)
10-K
2024-03-19
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Coya Therapeutics, Inc filed this 10-K on March 19, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6M
- compared with $0 a year earlier
- Net loss
- $7.99M
- compared with a net loss of $12.24M a year earlier
- Diluted EPS
- -$0.79
- compared with -$4.73 a year earlier